Similar articles

• Phage M13 for the treatment of Alzheimer and Parkinson disease.

  Messing J. Messing J. Gene. 2016 Jun 1;583(2):85-89. doi: 10.1016/j.gene.2016.02.005. Epub 2016 Feb 8. Gene. 2016. PMID: 26869319 Review.
• Tau and Parkinson disease.

  Spillantini MG, Goedert M. Spillantini MG, et al. JAMA. 2001 Nov 14;286(18):2324-6. doi: 10.1001/jama.286.18.2324. JAMA. 2001. PMID: 11710900 No abstract available.
• Alpha-synuclein and Parkinson's disease.

  Golbe LI. Golbe LI. Adv Neurol. 2003;91:165-74. Adv Neurol. 2003. PMID: 12442675 Review. No abstract available.
• alpha-Synuclein--a link between Parkinson and Alzheimer diseases?

  Heintz N, Zoghbi H. Heintz N, et al. Nat Genet. 1997 Aug;16(4):325-7. doi: 10.1038/ng0897-325. Nat Genet. 1997. PMID: 9241262 No abstract available.
• Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

  Goedert M. Goedert M. Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1101-18. doi: 10.1098/rstb.1999.0466. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434313 Free PMC article. Review.